Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3687-3698

  Nguyen, Tri Minh Bui ^a,d   Subramanian, Indira V ^a   Xiao, Xue ^d,e   Ghosh, Goutam ^a   Nguyen, Phan ^a   Kelekar, Ameeta ^b,c   Ramakrishnan, S ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Autophagy; Bcl 2; Bcl xL; Beclin 1; Beta catenin; Endostatin; Wnt pathway

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; BETA CATENIN; CASPASE; ENDOSTATIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; AUTOPHAGY; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; RNA INTERFERENCE; TIME; TUMOR CELL LINE; UMBILICAL VEIN;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BETA CATENIN; CASPASES; CELL LINE, TUMOR; ENDOSTATINS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; RNA INTERFERENCE; TIME FACTORS; UMBILICAL VEINS;

EID: 77449091329     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00722.x     Document Type: Article

References (41)

1. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
2. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov 2007, 6:273-86.
3. O'Reilly MS, Boehm T, Shing Y. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-85.
4. Abdollahi A, Hahnfeldt P, Maercker C. Endostatin's antiangiogenic signaling network. Mol Cell 2004, 13:649-63.
5. Yamaguchi N, Anand-Apte B, Lee M. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 1999, 18:4414-23.
6. Dhanabal M, Ramchandran R, Waterman MJ. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999, 274:11721-6.
7. Yokoyama Y, Ramakrishnan S. Improved biological activity of a mutant endostatin containing a single amino-acid substitution. Br J Cancer 2004, 90:1627-35.
8. Yokoyama Y, Ramakrishnan S. Binding of endostatin to human ovarian cancer cells inhibits cell attachment. Int J Cancer 2007, 121:2402-9.
9. Sudhakar A, Sugimoto H, Yang C. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 2003, 100:4766-71.
10. Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 2002, 62:5580-9.
11. Hanai J, Gloy J, Karumanchi SA. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 2002, 158:529-39.
12. Hoppler S, Kavanagh CL. Wnt signalling: variety at the core. J Cell Sci 2007, 120:385-93.
13. Nor JE, Christensen J, Mooney DJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999, 154:375-84.
14. Nor JE, Christensen J, Liu J. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001, 61:2183-8.
15. Pattingre S, Tassa A, Qu X. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-39.
16. Maiuri MC, Le Toumelin G, Criollo A. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007, 26:2527-39.
17. Pattingre S, Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res 2006, 66:2885-8.
18. Chau YP, Lin SY, Chen JH. Endostatin induces autophagic cell death in EAhy926 human endothelial cells. Histol Histopathol 2003, 18:715-26.
19. Yokoyama Y, Dhanabal M, Griffioen AW. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res 2000, 60:2190-6.
20. Bui Nguyen TM, Subramanian IV, Kelekar A. Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood 2007, 109:4793-802.
21. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 2002, 27:421-9.
22. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 2004, 313:453-8.
23. Kelekar A. Autophagy. Ann N Y Acad Sci 2006, 1066:259-71.
24. Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003, 13:137-45.
25. Kirkegaard K, Taylor MP, Jackswon WT. Cellular autography: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2004, 2:301-14.
26. Kabeya Y, Mizushima N, Ueno T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19:5720-8.
27. Tanida I, Minematsu-Ikeguchi N, Ueno T. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005, 1:84-91.
28. Brown CR, McCann JA, Hung GG. Vid22p, a novel plasma membrane protein, is required for the fructose-1,6-bisphosphatase degradation pathway. J Cell Sci 2002, 115:655-66.
29. Rehn M, Veikkola T, Kukk-Valdre E. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001, 98:1024-9.
30. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-906.
31. Hendil KB, Lauridsen AM, Seglen PO. Both endocytic and endogenous protein degradation in fibroblasts is stimulated by serum/amino acid deprivation and inhibited by 3-methyladenine. Biochem J 1990, 272:577-81.
32. Abedin MJ, Wang D, McDonnell MA. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007, 14:500-10.
33. Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J Biol Chem 2003, 278:37895-901.
34. Karumanchi SA, Jha V, Ramchandran R. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 2001, 7:811-22.
35. Maiuri MC, Zalckvar E, Kimchi A. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8:741-52.
36. Wild R, Dings RP, Subramanian I. Carboplatin selectively induces the VEGF stress response in endothelial cells: potentiation of antitumor activity by combination treatment with antibody to VEGF. Int J Cancer 2004, 110:343-51.
37. Lee S, Chen TT, Barber CL. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703.
38. Yang J, Liu X, Bhalla K. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-32.
39. Kluck RM, Bossy-Wetzel E, Green DR. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-6.
40. Cheng EH, Wei MC, Weiler S. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001, 8:705-11.
41. Taketo MM. Shutting down Wnt signal-activated cancer. Nat Genet 2004, 36:320-2.